A new coronavirus (SARS-CoV-2) is a global threat to world health
and economy. Its dimeric main protease (M
pro
), which
is required for the proteolytic cleavage of viral precursor
proteins, is a good candidate for drug development owing to its
conservation and the absence of a human homolog. Improving our
understanding of M
pro
behavior can accelerate the
discovery of effective therapies to reduce mortality. All-atom
molecular dynamics (MD) simulations (100 ns) of 50 mutant
M
pro
dimers obtained from filtered sequences
from the GISAID database were analyzed using root-mean-square
deviation, root-mean-square fluctuation,
R
g
, averaged betweenness
centrality, and geometry calculations. The results showed that
SARS-CoV-2 M
pro
essentially behaves in a similar
manner to its SAR-CoV homolog. However, we report the following
new findings from the variants: (1) Residues GLY15, VAL157, and
PRO184 have mutated more than once in SARS CoV-2; (2) the D48E
variant has lead to a novel “TSEEMLN”” loop
at the binding pocket; (3) inactive apo M
pro
does not
show signs of dissociation in 100 ns MD; (4) a non-canonical
pose for PHE140 widens the substrate binding surface; (5) dual
allosteric pockets coinciding with various stabilizing and
functional components of the substrate binding pocket were found
to display correlated compaction dynamics; (6) high betweenness
centrality values for residues 17 and 128 in all M
pro
samples suggest their high importance in dimer
stability—one such consequence has been observed for the
M17I mutation whereby one of the N-fingers was highly unstable.
(7) Independent coarse-grained Monte Carlo simulations suggest a
relationship between the rigidity/mutability and enzymatic
function. Our entire approach combining database preparation,
variant retrieval, homology modeling, dynamic residue network
(DRN), relevant conformation retrieval from 1-D kernel density
estimates from reaction coordinates to other existing approaches
of structural analysis, and data visualization within the
coronaviral M
pro
is also novel and is applicable to
other coronaviral proteins.